Cite
Evaluating the efficacy and safety of acotiamide in patients with esophagogastric junction outflow obstruction: study protocol for an investigator-initiated, multi-center, randomized, double-blind, placebo-controlled phase II trial
MLA
Mitsuru Esaki, et al. “Evaluating the Efficacy and Safety of Acotiamide in Patients with Esophagogastric Junction Outflow Obstruction: Study Protocol for an Investigator-Initiated, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase II Trial.” Trials, vol. 24, no. 1, July 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13063-023-07468-w.
APA
Mitsuru Esaki, Eikichi Ihara, Noriaki Manabe, Noriyuki Kawami, Katsuhiko Iwakiri, Junichi Akiyama, Shiko Kuribayashi, Toshio Uraoka, Haruei Ogino, Takatoshi Chinen, Akiko Misumi, Hiroko Watanabe, Maya Suzuki, Junji Kishimoto, & Yoshihiro Ogawa. (2023). Evaluating the efficacy and safety of acotiamide in patients with esophagogastric junction outflow obstruction: study protocol for an investigator-initiated, multi-center, randomized, double-blind, placebo-controlled phase II trial. Trials, 24(1), 1–12. https://doi.org/10.1186/s13063-023-07468-w
Chicago
Mitsuru Esaki, Eikichi Ihara, Noriaki Manabe, Noriyuki Kawami, Katsuhiko Iwakiri, Junichi Akiyama, Shiko Kuribayashi, et al. 2023. “Evaluating the Efficacy and Safety of Acotiamide in Patients with Esophagogastric Junction Outflow Obstruction: Study Protocol for an Investigator-Initiated, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase II Trial.” Trials 24 (1): 1–12. doi:10.1186/s13063-023-07468-w.